Clinical Trial Update: Study of Xeloda and Gleevec in Patients With Advanced Solid Tumors [Phase 1]

View source ↗

Summary

Phase 1 study evaluating the combination of capecitabine (Xeloda) and imatinib (Gleevec) in patients with advanced solid tumors, including colon and colorectal …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colon Cancer
• Colorectal Cancer

Drugs mentioned

• Gleevec (Imatinib)
• Xeloda (capecitabine)

Snippet

Sponsor: University of Southern California | Conditions: Colon Cancer, Colorectal Cancer | Phase 1 | Status: COMPLETED